Following a similar strategy, Zhang et al. identified five upregulated plasma lncRNAs (TINCR, CCAT2, AOC4P, BANCR, and LINC00857) that were able to distinguish GC patients with an AUC of 0.90 in the validation cohort (80 GC patients and 80 healthy individuals). This evidence concerns the gene AOC4P and gastric cancer.